SBIO

ALPS Medical Breakthroughs ETF

Up$41.72
+$0.01
(+0.02%)
As of 9:04:00 PM EDT | 1/22/20  |  Market Closed

SBIO Trading Data

Open

$42.04

Low Price

$41.64

High Price

$42.1

Previous Last Price

$41.71

Bid Size

$0 X 0

Ask Size

$0 X 0

SBIO Portfolio Data

AUM

$221,222,000

Shares

5,300

PE Ratio

0

Price / Book Ratio

3.92

Expense Ratio

0.5

Net Asset Value

$41.74

Volume

Volume

31,700

Avg. Volume (YDT)

69,771

Dollar Volume

$3,390,064

Weekly Avg. Volume

56,860

Monthly Avg. Volume

65,460

Quarterly Avg. Volume

49,982

SBIO Fund Description

The ALPS Medical Breakthroughs ETF invests in the public equity markets of the United States. It invests in the stocks of companies operating in the biotechnology and pharmaceutical sectors. The fund invests in stocks of mid cap and small cap companies with a market capitalization of no less than $200 million and no more than $5 billion. It seeks to replicate the performance of the Poliwogg Medical Breakthroughs Index, by investing in the stocks of companies as per their weightings in the index.

SBIO Chart

SBIO Summary

Fund Family

ALPS Holdings

Tracks This Index

ALPS Medical Breakthroughs ETF

Inception Date

2015-01-05

Asset Class

Portfolio-Multi Asset

Asset Class Size

Healthcare

SBIO Classification

Region (General)

Global

Region (Specific)

Sector

Health Care

Equity Index

Leveraged Family

SBIO Holdings

Top 10 Holdings

Bluebird Bio Inc. (BLUE)
4.87%
Global Blood Therapeutics Inc. (GBT)
4.52%
MorphoSys AG (MOR)
3.75%
United Therapeutics Corp. (UTHR)
3.66%
Immunomedics Inc. (IMMU)
3.51%
FibroGen Inc. (FGEN)
3.47%
Mirati Therapeutics Inc. (MRTX)
3.43%
Deciphera Pharmaceuticals Inc. (DCPH)
3.18%
Intercept Pharmaceuticals Inc. (ICPT)
3.11%
Allakos Inc. (ALLK)
2.99%

Total SBIO Holdings

Total Holdings: 72

Bluebird Bio Inc. (BLUE)
4.87%
Global Blood Therapeutics Inc. (GBT)
4.52%
MorphoSys AG (MOR)
3.75%
United Therapeutics Corp. (UTHR)
3.66%
Immunomedics Inc. (IMMU)
3.51%
FibroGen Inc. (FGEN)
3.47%
Mirati Therapeutics Inc. (MRTX)
3.43%
Deciphera Pharmaceuticals Inc. (DCPH)
3.18%
Intercept Pharmaceuticals Inc. (ICPT)
3.11%
Allakos Inc. (ALLK)
2.99%
PTC Therapeutics Inc. (PTCT)
2.97%
Alkermes PLC (ALKS)
2.72%
Acceleron Pharma Inc. (XLRN)
2.67%
uniQure NV (QURE)
2.59%
Karuna Therapeutics Inc. (KRTX)
2.44%
Apellis Pharmaceuticals Inc. (APLS)
2.32%
ChemoCenyx Inc. (CCXI)
2.28%
Epizyme Inc. (EPZM)
2.18%
Arena Pharmaceuticals Inc. (ARNA)
2.1%
Eidos Therapeutics Inc. (EIDX)
1.86%
Principia Biopharma Inc. (PRNB)
1.85%
Ironwood Pharmaceuticals Inc. (IRWD)
1.77%
Fate Therapeutics Inc. (FATE)
1.74%
Zymeworks Inc. (ZYME)
1.73%
Akcea Therapeutics Inc. (AKCA)
1.44%
Ligand Pharmaceuticals Inc. (LGND)
1.42%
Cortexyme Inc. (CRTX)
1.41%
SpringWorks Therapeutics Inc. (SWTX)
1.37%
Alector Inc. (ALEC)
1.32%
Dicerna Pharmaceuticals Inc. (DRNA)
1.31%
Constellation Pharmaceuticals Inc. (CNST)
1.23%
Orchard Therapeutics PLC (ORTX)
1.22%
Coherus Biosciences Inc. (CHRS)
1.21%
Madrigal Pharmaceuticals Inc. (MDGL)
1.18%
Enanta Pharmaceuticals Inc. (ENTA)
1.02%
Portola Pharmaceuticals Inc. (PTLA)
0.98%
Rocket Pharmaceuticals Inc. (RCKT)
0.94%
XBiotech Inc. (XBIT)
0.9%
G1 Therapeutics Inc. (GTHX)
0.85%
Gossamer Bio Inc. (GOSS)
0.85%
Krystal Biotech Inc. (KRYS)
0.8%
Aprea Therapeutics Inc. (APRE)
0.75%
Vericel Corp. (VCEL)
0.71%
Frequency Therapeutics Inc. (FREQ)
0.69%
MeiraGTx Holdings PLC (BFYQFJ)
0.67%
UroGen Pharma Ltd. (URGN)
0.64%
ImmunoGen Inc. (IMGN)
0.62%
Replimune Group Inc. (REPL)
0.61%
Kura Oncology Inc. (KURA)
0.52%
Crinetics Pharmaceuticals Inc. (CRNX)
0.52%
Akero Therapeutics Inc. (AKRO)
0.52%
Oyster Point Pharma Inc. (OYST)
0.51%
MacroGenics Inc. (MGNX)
0.5%
Agenus Inc. (AGEN)
0.49%
Viking Therapeutics Inc. (VKTX)
0.47%
Voyager Therapeutics Inc. (VYGR)
0.46%
Rigel Pharmaceuticals Inc. (RIGL)
0.44%
Merus NV (MRUS)
0.43%
Assembly Biosciences Inc. (ASMB)
0.42%
Catalyst Pharmaceuticals Inc. (CPRX)
0.39%
PDL BioPharma Inc. (PDLI)
0.34%
Puma Biotechnology Inc. (PBYI)
0.34%
CytomX Therapeutics Inc. (CTMX)
0.31%
KalVista Pharmaceuticals Inc. (KALV)
0.3%
Albireo Pharma Inc. (ALBO)
0.29%
MediciNova Inc. (MNOV)
0.28%
Concert Pharmaceuticals Inc. (CNCE)
0.22%
XOMA Corp. (XOMA)
0.21%
GlycoMimetics Inc. (GLYC)
0.19%
ALPS Medical Breakthroughs ETF (SBIO)
0%
Cash Equivalent
0%
Corium International Inc. (CORI-CVR)
0%

SBIO Technicals

Alpha

5.04

Beta

1.63

Leverage

Long

Standard Deviation

3.03

SBIO Dividends

Dividend Date

2019-12-19

Latest Dividend

0.016

Annual Dividend

0.02

Annual Dividend Rate

0.02

Annual Dividend Yield

0.04

SBIO Performance

YTD Return

-1.32%

1 Year Return

32.15%

3 Year Return

82.18%

5 Year Return

55.67%

10 Year Return

67.95%

SBIO Related Articles

© 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.

Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.